Advancing Our Robust and High Potential Pipeline

Target Validation
Lead Discovery
Lead Optimization
IND-Enabling Studies
+
PSY-05Generalized Anxiety Disorder (GAD)
Post-Traumatic Stress Disorder (PTSD)
+
PSY-06Anxious Depression
+
PSY-01Major Depressive Disorder (MDD)
Parkinson’s Disease (PD)
+
PSY-02Alzheimer’s Disease (AD) and related Tauopathies
+
Targets #5-8Various CNS Indications